RSS-Feed abonnieren
DOI: 10.1055/s-0029-1186192
© Georg Thieme Verlag KG Stuttgart · New York
Anti-Leishmanial Lindenane Sesquiterpenes from Hedyosmum angustifolium
Publikationsverlauf
received May 4, 2009
revised August 19, 2009
accepted September 11, 2009
Publikationsdatum:
14. Oktober 2009 (online)
Abstract
The aim of this work is the isolation of anti-leishmanial compounds from the ethyl acetate extracts of the bark of Hedyosmum angustifolium. We have successfully isolated and characterized five sesquiterpenes: one new compound (oxyonoseriolide, 1), one compound isolated for the first time from a natural source (hedyosmone, 2), and three known sesquiterpenes (onoseriolide, 3; chloranthalactone A, 4; and spathulenol, 5) that had not been previously isolated from H. angustifolium. The biological activities of 1−5 showed that onoseriolide (3) was the most active compound against axenic amastigotes from Leishmania amazonensis and L. infantum. Moreover, it was still active on the intramacrophagic amastigotes of L. infantum. The isolated compounds have also been tested on Plasmodium falciparum and against various mammalian cell lines.
Key words
Hedyosmum angustifolium - Chloranthaceae - lindenane sesquiterpene - anti‐leishmanial - intramacrophagic amastigotes - luciferase
- Supporting Information for this article is available online at
- Supporting Information .
References
- 1 Desjeux P. Worldwide increasing risk factors for leishmaniasis. Med Microbiol Immunol. 2001; 190 77-79
- 2 Sanchez A. Anuario epidemiológico. La Paz; Servicio nacional de leishmaniasis Ministerio Boliviano de Salud 2000: 1-150
- 3 Mollinedo S, Torrez M, Holguin E, Vargas F. Leishmaniasis en Bolivia: X. Epidemiologia de fin de siglo. Rev Med. 2000; 7 1-15
- 4 Sereno D, Cordeiro da Silva A, Mathieu-Daude F, Ouaissi A. Advances and perspectives in Leishmania cell based drug-screening procedures. Parasitol Int. 2007; 56 3-7
- 5 Acebey L, Apaza A, de Michel R, Beck S, Jullian V, Ruiz G, Gimenez A, Chevalley S, Sauvain M. The living library of The Cotapata National Park in Bolivia: an example of application of Bolivian law on the access to genetic resources. Biodivers Conserv. 2008; 17 1853-1859
- 6 Acebey L, Sauvain M, Beck S, Moulis C, Gimenez A, Jullian V. Bolivianine, a new sesterpene with an unusual skeleton from Hedyosmum angustifolium, and its isomer, isobolivianine. Org Lett. 2007; 9 4693-4696
- 7 Lorenzo D, Loayza I, Dellacassa E. Composition of the essential oils from leaves of two Hedyosmum spp. from Bolivia. Flavour Fragrance J. 2003; 18 32-35
- 8 Cardenas L C, Rodriguez J, Villaverde M C, Riguera R, Cadena R, Otero J A. The analgesic activity of Hedyosmum bonplandianum: flavonoid glycosides. Planta Med. 1993; 59 26-27
- 9 Bercion S, Couppe de K, Martin M A, Baltaze J P, Bourgeois P. A new α-methylene γ-lactone sesquiterpene from Hedyosmum arborescens. Fitoterapia. 2005; 76 620-624
- 10 Trentin A P, Santos A R S, Guedes A, Pizzolatti M G, Yunes R A, Calixto J B. Antinociception caused by the extract of Hedyosmum brasiliense and its active principle, the sesquiterpene lactone 13-hydroxy-8,9-dehydroshizukanolide. Planta Med. 1999; 65 517-521
- 11 Su Z S, Yin S, Zhou Z W, Wu Y, Ding J, Yue J M. Sesquiterpenoids from Hedyosmum orientale. J Nat Prod. 2008; 71 1410-1413
- 12 Sereno D, Lemesre J L. Axenically cultured amastigote forms as an in vitro model for investigation of antileishmanial agents. Antimicrob Agents Chemother. 1997; 41 972-976
- 13 Bittner M, Jakupovic J, Bohlmann F, Silva M. Onoseriolide derivatives from Leuceria species. Phytochemistry. 1989; 28 271-273
- 14 Ushida M, Koike U, Kusano G, Kondo Y, Nozoe S, Kabuto C, Takemoto T. Studies on the constituent of Chloranthus spp. III. Six sesquiterpenes from Chloranthus japonicus. Chem Pharm Bull. 1980; 28 92-102
- 15 Kawabata J, Tahara S, Mizutani J. Isolation and structural elucidation of four sesquiterpenes from Chloranthus japonicus (Chloranthaceae). Agric Biochem Chem. 1981; 45 1447-1453
- 16 Bohlmann F, Zdero C, King R M, Robinson H. Onoseriolid, ein neues Sesquiterpenlacton aus Onoseris albicans. Phytochemistry. 1980; 19 689-691
- 17 Takeda Y, Yamashita H, Matsumoto T, Terao H. Chloranthalactone F, a sesquiterpenoid from the leaves of Chloranthus glaber. Phytochemistry. 1993; 33 713-715
- 18 Tsui W Y, Brown G D. Cycloeudesmanolides from Sarcandra glabra. Phytochemistry. 1996; 43 819-821
- 19 Krebs H C, Rakotoarimanga J V, Habermehl G G. Isolation of spathulenol and (−)-caryophyllene oxide from Vernonia mollissima don and 1H and 13C reassignment by two-dimensional NMR spectroscopy. Magn Reson Chem. 1990; 28 124-128
- 20 Sereno D, Lemesre J L. Use of an enzymatic micromethod to quantify amastigote stage of Leishmania amazonensis in vitro. Parasitol Res. 1997; 83 401-403
- 21 Sereno D, Roy G, Lemesre J L, Papadopoulou B, Ouellette M. DNA transformation of Leishmania infantum axenic amastigotes and their use in drug screening. Antimicrob Agents Chemother. 2001; 45 1168-1173
- 22 Zhang S, Won Y K, Ong C N, Shen H M. Anti-cancer potential of sesquiterpene lactones: bioactivity and molecular mechanisms. Curr Med Chem Anticancer Agents. 2005; 5 239-249
- 23 Calera M R, Soto F, Sanchez P, Bye R, Hernandez-Bautista B, Anaya A L, Lotina-Hennsen B, Mata R. Biochemically active sesquiterpene lactones from Ratibida mexicana. Phytochemistry. 1995; 40 419-425
- 24 Dirsch V M, Stuppner H, Ellmerer-Müller E P, Vollmar A M. Structural requirements of sesquiterpene lactones to inhibit LPS-induced nitric oxide synthesis in RAW 264.7 macrophages. Bioorg Med Chem. 2000; 8 2747-2753
- 25 Trager W, Jensen J B. Human malaria parasites in continuous culture. Science. 1976; 193 673-675
- 26 Valentin A, Benoit-Vical F, Moulis C, Stanislas E, Mallie M, Fouraste I, Bastide J M. In vitro antimalarial activity of penduline, a bisbenzylisoquinoline from Isopyrum thalictroides. Antimicrob Agents Chemother. 1997; 41 2305-2307
- 27 Desjardins R E, Canfield C J, Haynes J D, Chulay J D. Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique. Antimicrob Agents Chemother. 1979; 16 710-718
Michel Sauvain
Institut de Recherche pour le Développement
UMR-152
Mission IRD
Casilla 18
1209 Lima
Peru
Telefon: + 51 14 81 17 94
Fax: + 51 14 42 32 23
eMail: michel.sauvain@ird.fr
- www.thieme-connect.de/ejournals/toc/plantamedica